Biosimilar Clinical Development Solution novumprs.com
Reliable. Secure. Since 2012. Exchange Crypto Sign up to get a trading fee discount!
Novum’s experienced global team of scientists, physicians, and respected CRO industry professionals will collaborate with your team to develop a pathway for your biosimilar clinical product development programs.
Biosimilars are Becoming a Key Sector of the Global Pharmaceutical Market
88.5% of prescriptions filled are for unbranded generic drugs
Biosimilars are gaining traction and will continue to grow in market share
Since 2006:
US – 35 biosimilars approved by FDA
EU – 55 biosimilars approved by EMA
